Chen, X., Shi, J., Lai, Y., Xue, Y., Ung, C. O. L., & Hu, H. (2023). Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): Implications for future drug development and trial design. Chinese Medicine, 18(1), 1. https://doi.org/10.1186/s13020-023-00761-5
Chicago Style (17th ed.) CitationChen, Xianwen, Junnan Shi, Yunfeng Lai, Yan Xue, Carolina Oi Lam Ung, and Hao Hu. "Systematic Analysis of Randomised Controlled Trials of Chinese Herb Medicine for Non-alcoholic Steatohepatitis (NASH): Implications for Future Drug Development and Trial Design." Chinese Medicine 18, no. 1 (2023): 1. https://doi.org/10.1186/s13020-023-00761-5.
MLA (9th ed.) CitationChen, Xianwen, et al. "Systematic Analysis of Randomised Controlled Trials of Chinese Herb Medicine for Non-alcoholic Steatohepatitis (NASH): Implications for Future Drug Development and Trial Design." Chinese Medicine, vol. 18, no. 1, 2023, p. 1, https://doi.org/10.1186/s13020-023-00761-5.